These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 18508558)

  • 1. Arterial remodeling in vascular disease: a key role for hyaluronan and versican.
    Wight TN
    Front Biosci; 2008 May; 13():4933-7. PubMed ID: 18508558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-derived growth factor stimulates the formation of versican-hyaluronan aggregates and pericellular matrix expansion in arterial smooth muscle cells.
    Evanko SP; Johnson PY; Braun KR; Underhill CB; Dudhia J; Wight TN
    Arch Biochem Biophys; 2001 Oct; 394(1):29-38. PubMed ID: 11566024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation of hyaluronan- and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells.
    Evanko SP; Angello JC; Wight TN
    Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):1004-13. PubMed ID: 10195929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-beta as a key molecule triggering the expression of versican isoforms v0 and v1, hyaluronan synthase-2 and synthesis of hyaluronan in malignant osteosarcoma cells.
    Nikitovic D; Zafiropoulos A; Katonis P; Tsatsakis A; Theocharis AD; Karamanos NK; Tzanakakis GN
    IUBMB Life; 2006 Jan; 58(1):47-53. PubMed ID: 16540432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Provisional matrix: A role for versican and hyaluronan.
    Wight TN
    Matrix Biol; 2017 Jul; 60-61():38-56. PubMed ID: 27932299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteoglycans in atherosclerosis and restenosis: key roles for versican.
    Wight TN; Merrilees MJ
    Circ Res; 2004 May; 94(9):1158-67. PubMed ID: 15142969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Versican-A Critical Extracellular Matrix Regulator of Immunity and Inflammation.
    Wight TN; Kang I; Evanko SP; Harten IA; Chang MY; Pearce OMT; Allen CE; Frevert CW
    Front Immunol; 2020; 11():512. PubMed ID: 32265939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of the V3 variant of versican alters arterial smooth muscle cell adhesion, migration, and proliferation in vitro.
    Lemire JM; Merrilees MJ; Braun KR; Wight TN
    J Cell Physiol; 2002 Jan; 190(1):38-45. PubMed ID: 11807809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genistein selectively inhibits platelet-derived growth factor-stimulated versican biosynthesis in monkey arterial smooth muscle cells.
    Schönherr E; Kinsella MG; Wight TN
    Arch Biochem Biophys; 1997 Mar; 339(2):353-61. PubMed ID: 9056268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sirolimus blocks the accumulation of hyaluronan (HA) by arterial smooth muscle cells and reduces monocyte adhesion to the ECM.
    Gouëffic Y; Potter-Perigo S; Chan CK; Johnson PY; Braun K; Evanko SP; Wight TN
    Atherosclerosis; 2007 Nov; 195(1):23-30. PubMed ID: 17174314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crosstalk Between T Lymphocytes and Lung Fibroblasts: Generation of a Hyaluronan-Enriched Extracellular Matrix Adhesive for Monocytes.
    Gaucherand L; Falk BA; Evanko SP; Workman G; Chan CK; Wight TN
    J Cell Biochem; 2017 Aug; 118(8):2118-2130. PubMed ID: 27982477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lp3/Hapln3, a novel link protein that co-localizes with versican and is coordinately up-regulated by platelet-derived growth factor in arterial smooth muscle cells.
    Ogawa H; Oohashi T; Sata M; Bekku Y; Hirohata S; Nakamura K; Yonezawa T; Kusachi S; Shiratori Y; Ninomiya Y
    Matrix Biol; 2004 Aug; 23(5):287-98. PubMed ID: 15464361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronan and versican in the control of human T-lymphocyte adhesion and migration.
    Evanko SP; Potter-Perigo S; Bollyky PL; Nepom GT; Wight TN
    Matrix Biol; 2012 Mar; 31(2):90-100. PubMed ID: 22155153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of versican V3 by arterial smooth muscle cells alters tumor growth factor β (TGFβ)-, epidermal growth factor (EGF)-, and nuclear factor κB (NFκB)-dependent signaling pathways, creating a microenvironment that resists monocyte adhesion.
    Kang I; Yoon DW; Braun KR; Wight TN
    J Biol Chem; 2014 May; 289(22):15393-404. PubMed ID: 24719328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibulin-2 is present in murine vascular lesions and is important for smooth muscle cell migration.
    Ström A; Olin AI; Aspberg A; Hultgårdh-Nilsson A
    Cardiovasc Res; 2006 Feb; 69(3):755-63. PubMed ID: 16409997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of versican V0/V1 and CD44 in the regulation of human melanoma cell behavior.
    Hernández D; Miquel-Serra L; Docampo MJ; Marco-Ramell A; Bassols A
    Int J Mol Med; 2011 Feb; 27(2):269-75. PubMed ID: 21136024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of versican synthesis by antisense alters smooth muscle cell phenotype and induces elastic fiber formation in vitro and in neointima after vessel injury.
    Huang R; Merrilees MJ; Braun K; Beaumont B; Lemire J; Clowes AW; Hinek A; Wight TN
    Circ Res; 2006 Feb; 98(3):370-7. PubMed ID: 16385080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential accumulation of proteoglycans and hyaluronan in culprit lesions: insights into plaque erosion.
    Kolodgie FD; Burke AP; Farb A; Weber DK; Kutys R; Wight TN; Virmani R
    Arterioscler Thromb Vasc Biol; 2002 Oct; 22(10):1642-8. PubMed ID: 12377743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host stromal versican is essential for cancer-associated fibroblast function to inhibit cancer growth.
    Fanhchaksai K; Okada F; Nagai N; Pothacharoen P; Kongtawelert P; Hatano S; Makino S; Nakamura T; Watanabe H
    Int J Cancer; 2016 Feb; 138(3):630-41. PubMed ID: 26270355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A role for versican in the development of leiomyosarcoma.
    Keire PA; Bressler SL; Lemire JM; Edris B; Rubin BP; Rahmani M; McManus BM; van de Rijn M; Wight TN
    J Biol Chem; 2014 Dec; 289(49):34089-103. PubMed ID: 25320080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.